1st Quarter - Termination

RUBICON ADVISORS, LLC for AQUESTIVE THERAPEUTICS, INC

Firm
Client
Income
—
Expenses
—
Terminated
Jan 1, 2023

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 20, 2023 $45,000 Yes
1st Quarter - Termination (this page) Jul 21, 2024 — Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R, 1629/S 250: Fairness in Orphan Drug Exclusivity Act

LobbyistCovered position, as disclosed
WILLIAM BURKE —

Contacted: Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.